Pharmacovigilance and Adverse Event Reporting: Responsibilities of the Supplier
Pharmacovigilance (PV) is primarily associated with manufacturers and healthcare providers, but suppliers play an essential role in detecting and reporting safety signals that affect public health.
Establish an internal procedure for receiving, documenting, and forwarding adverse event reports. Customer service teams and delivery personnel must know how to capture critical information: product identification (including batch/lot), description of the event, patient demographics (as available), and reporter contact details. Maintain confidentiality and data protection compliance when handling health information.
Suppliers should have clear escalation pathways to the responsible marketing authorization holder or manufacturer and to regulatory authorities when required. Time is important ā some jurisdictions mandate expedited reporting windows for serious or unexpected adverse events. Familiarize yourself with reporting obligations in the markets you serve.
Signal detection also includes product quality complaints and counterfeit suspicions. Capture trends in complaints and maintain a trending dashboard to spot clusters early. When investigations suggest a quality or safety issue, collaborate with manufacturers and regulators to enable targeted recalls or communications.
Training staff on PV basics and establishing reliable documentation ensures your business contributes to patient safety. By acting as a vigilant point in the supply chain, Pharmcomix can strengthen public health protections and the trust of clinical customers.
